SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus

Aventus ($AVT.X) is trending as the community discusses its potential for a bullish breakout, citing strong support and accumulation. Many users are highlighting the token's low market cap and supply, along with partnerships and technology, as reasons for optimism. Some traders are drawing attention to chart patterns and potential targets while others are comparing it to similar crypto assets.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending upwards, driven by a mix of potential Q3 delivery beats, optimism around future growth areas like robotics and energy storage, and anticipation of upcoming Fed rate cuts. Community discussions revolve around the stock's momentum, potential short squeezes, and debate over Elon Musk's influence on the company.

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY.X is gaining traction as the 'original gangster' meme, with the community rallying around its cultural significance and the formation of a strong 'cult'. Discussions highlight the coin's resilience during market dips and the community's conviction that $LENNY represents more than just a memecoin, but a movement.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is surging, driven by a recent listing on major exchanges like Binance, sparking significant buying pressure and high trading volume. The community is buzzing with excitement, anticipating further price increases and drawing comparisons to other successful tokens. Many believe this is just the beginning, with some speculating about substantial gains in the near future.

Assemble’s AI agent, News3(NS3), was developed with the goal of revolutionizing Web 3.0 journalism. NS3 delivers crypto and global economic trends quickly and clearly, and leverages advanced AI reasoning capabilities to analyze these trends, enabling market participants to make data-driven decisions. In particular, NS3 utilizes OpenAI’s latest reasoning model as its core engine to analyze crypto and economic trends, providing a range of insights including market psychology, past case analysis, future predictions, ripple effects, and investment strategies in 12 languages.

Assemble Protocol

Assemble Protocol ($ASM.X) is trending as traders discuss potential whale manipulation and accumulation, with some speculating about an impending pump. Community members are analyzing price charts and anticipating a breakout, while also debating the coin's utility and potential for significant gains. There's also discussion around a potential listing on a major exchange.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

The community is buzzing about aTyr Pharma as they anticipate the release of Phase 3 trial data for Efzofitimod, a drug targeting pulmonary sarcoidosis; many expect the data drop sometime next week. Community talking points range from potential FDA approval and buyout scenarios to skepticism fueled by bearish perspectives. Some traders are strategizing around options, with implied volatility high as the community speculates on whether the results will trigger a short squeeze or a significant price drop.

CTX is a governance token that powers and secures the Cryptex protocol. Holders of CTX can vote on protocol upgrades for TCAP as well as all future products within the Cryptex ecosystem.

Cryptex Finance

Cryptex Finance's CTX.X is gaining attention as traders discuss its potential for significant rallies due to its low market cap and circulating supply. Some community members are frustrated with the lack of communication from the team, while others remain optimistic, citing upcoming catalysts and potential for growth. Conversations also highlight its association with meetings with regulatory bodies such as the SEC.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as discussions revolve around lobbying efforts and a potential meeting with President Trump amidst an ongoing DOJ probe, with community members debating the impact of these factors. Some believe a resolution to the probe is near, while others speculate about the potential for increased regulatory challenges. Retail traders remain bullish on the stock's long-term prospects.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending as traders discuss the company's recent $20 million investment agreement and upcoming presentation at a virtual investor summit, anticipating potential catalysts and news. Community members are weighing the potential for a short squeeze given the low float and upcoming events, while others caution about potential dilution and past reverse splits. The company's glucose monitoring technology and potential competition with larger players like Dexcom and Abbott are also key discussion points.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community buzzes about its resilience and consistent growth over the past nine months. Active discussions revolve around breaking new ATHs, a live buy contest, and an upcoming listing on Bifinance, with community members emphasizing its strong foundation and transparent development.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Carlyle Agrees to Buy intelliflo From Invesco for $200 Million

CG is set to acquire intelliflo from Invesco for up to $200M, boosting its wealthtech reach in the UK, the United States, and Australia.


First Financial to Acquire BankFinancial, Expands Chicago Presence (Revised)

FFBC is set to acquire BankFinancial in a $142M all-stock deal, expanding its Chicago footprint with 18 financial centers.

First Financial to Acquire BankFinancial, Expands Chicago Presence

THFF is set to acquire BankFinancial in a $142M all-stock deal, expanding its Chicago footprint with 18 financial centers.

Glacier Bancorp (GBCI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Glacier Bancorp (GBCI) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Glacier Bancorp (GBCI) Lags Q2 Earnings and Revenue Estimates

Glacier Bancorp (GBCI) delivered earnings and revenue surprises of -4.26% and -1.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Northrim BanCorp (NRIM) Lags Q2 Earnings Estimates

Northrim (NRIM) delivered earnings and revenue surprises of -7.52% and +3.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Exploring Analyst Estimates for Glacier Bancorp (GBCI) Q2 Earnings, Beyond Revenue and EPS

Evaluate the expected performance of Glacier Bancorp (GBCI) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Bank of Marin (BMRC) Earnings Expected to Grow: Should You Buy?

Bank of Marin (BMRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Huntington to Strengthen Texas Presence With Veritex Buyout 

HBAN announces a $1.9 billion all-stock definitive agreement to acquire Veritex, aiming to expand in the Dallas/Fort Worth and Houston areas.

Glacier Bancorp (GBCI) Earnings Expected to Grow: Should You Buy?

Glacier Bancorp (GBCI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Glacier Bancorp, Inc. engages in the provision of banking services to individuals and businesses. Its portfolio segment of loans includes residential, commercial, and other commercial real estate, home equity, and other consumer. The firm also offers retail banking, business banking, real estate, commercial, agriculture, and consumer loans, and mortgage origination and loan servicing. The company was founded in 1955 and is headquartered in Kalispell, MT.

Current Price	$48.92
Prev Close	$48.94
Open	$48.59
Dividend Yield	2.63%
50-Day Moving Average	$46.40
Beta	1.20
Avg. Volume	767,268.29
PE Ratio	25.40

52-Week High	$60.67
52-Week Low	$36.76
Market Capitalization	$5.8B
EPS (Annual)	$1.68
Price to Book	1.64
Revenue Per Employee	$368,520.49
Enterprise Value/EBITDA	N/A

GBCI
Glacier Bancorp, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GBCI News

GBCI Glacier Bancorp, Inc.